Showing results (2631-2640 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|January 11, 2024
A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for LymphomaMichael Durando, Ajay K Gopal, Joseph Tuscano, et al.
The Oncologist|January 11, 2024
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery ModeAlice Avancini, Anita Borsati, Elisabetta Baldo, et al.
The Oncologist|January 3, 2024
First-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor ActivityErkut Borazanci, Ashok Saluja, Jon Gockerman, et al.
The Oncologist|December 30, 2023
Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging FeaturesHop S Tran Cao, Russell G Witt, Khaled M Elsayes, et al.
The Oncologist|January 5, 2024
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal CancerStephanie L Alden, Valerie Lee, Amol K Narang, et al.
The Oncologist|December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
The Oncologist|December 18, 2023
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery ProtocolIlse A C Spiekman, Birgit S Geurts, Laurien J Zeverijn, et al.
The Oncologist|December 9, 2023
Methotrexate Scarcity Among Children's Oncology Group Institutions: Results of a Multinational SurveySarah Menig, Olga Militano, Andrew Ostrenga, et al.
The Oncologist|December 4, 2023
The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023Toni K Choueiri, Sumanta K Pal, Bryan Lewis, et al.
The Oncologist|November 30, 2023
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint TherapyAndrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, et al.
Pageof 571